Pharmaceutical Executive-11-01-2012

Issue PDF
Pharmaceutical Executive

November 01, 2012

Pharm Exec's 2013 Pipeline Report

Pharmaceutical Executive
Column

November 01, 2012

For the second time in recent memory, a top European regulator leaves office abruptly and under a cloud of suspicion.

Pharmaceutical Executive

How an agency and client behave after they split speaks volumes about their culture and character, writes Al Topin.

Pharmaceutical Executive
Column

November 01, 2012

While the nation was embroiled in the presidential elections, a number of important legal and regulatory issues absorbed pharmaceutical executives, writes Jill Wechsler.

Pharmaceutical Executive
Features

November 01, 2012

Providers and patients fish for that delicate balance between access and abandonment.

Pharmaceutical Executive
Column

November 01, 2012

Over-the-counter products face a new wave of regulation.

Pharmaceutical Executive
Column

November 01, 2012

Prix Galien celebrates a new round of next generation drug technologies.

Pharmaceutical Executive
Column

November 01, 2012

Commercial teams as well as patients can benefit from managed access programs.

Pharmaceutical Executive
From the Editor

November 01, 2012

Spain's leading business school, IESE, organized an expert conference on October 2-3 to address two simple questions. First, how can providers and payers work together to generate more value from existing resources? Second, what must be done to ensure the system continues to create value in the first place?

Pharmaceutical Executive
Column

November 01, 2012

Unified payer research planning is of top import.

Pharmaceutical Executive
Features

November 01, 2012

Is the 'lost decade' of declining pipeline productivity finally over? Our annual survey of analyst assessments of the state of drug development suggests so...

Pharmaceutical Executive
Country Report

November 01, 2012

The '90s was an enthusiastic time. With the fall of communism in 1989 and the emergence of the free economy, the international pharmaceutical industry arrived in the Czech Republic to find a highly receptive market.

Pharmaceutical Executive

Chinese start-ups have realized that they need to recruit highly skilled and globally oriented general managers from foreign multinationals when they reach a critical size.